UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 338

Sortiert nach

Efficacy of Bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis

The Journal of urology, 2017-09, Vol.198 (3), p.503-510

2017

Volltextzugriff (PDF)

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

European urology, 2020-10, Vol.78 (4), p.533-537

2020

Volltextzugriff (PDF)

Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial

European urology, 2014-08, Vol.66 (2), p.265-272

2014

Volltextzugriff (PDF)

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers

European urology, 2013-01, Vol.63 (1), p.4-15

2013

Volltextzugriff (PDF)

Definition, Incidence, Risk Factors, and Prevention of Paralytic Ileus Following Radical Cystectomy: A Systematic Review

European urology, 2013-10, Vol.64 (4), p.588-597

2013

Volltextzugriff (PDF)

Chemoradiation Vs Radical Cystectomy for Muscle-invasive Bladder Cancer: A Propensity Score-weighted Comparative Analysis Using the National Cancer Database

Urology (Ridgewood, N.J.), 2019-11, Vol.133, p.164-174

2019

Volltextzugriff (PDF)

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer

World journal of urology, 2019-01, Vol.37 (1), p.3-13

2019

Volltextzugriff (PDF)

Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model

Experimental gerontology, 2018-05, Vol.105, p.146-154

2018

Volltextzugriff (PDF)

Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients

The Journal of urology, 2010-06, Vol.183 (6), p.2165-2170

2010

Volltextzugriff (PDF)

A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2/N3)

Frontiers in oncology, 2024-01, Vol.13, p.1157880-1157880

2024

Volltextzugriff (PDF)

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Cancer medicine (Malden, MA), 2021-03, Vol.10 (6), p.2137-2152

2021

Volltextzugriff (PDF)

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial

Oncoimmunology, 2019-08, Vol.8 (8), p.1614857

2019

Volltextzugriff (PDF)

Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial

Clinical cancer research, 2015-01, Vol.21 (2), p.303-311

2015

Volltextzugriff (PDF)

The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease

European urology, 2014-08, Vol.66 (2), p.253-262

2014

Volltextzugriff (PDF)

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Future oncology (London, England), 2019-05, Vol.15 (15), p.1683-1695

2019

Volltextzugriff (PDF)

Impact of rural residence on the presentation, management and survival of patients with non-metastatic muscle-invasive bladder carcinoma

Investigative and clinical urology, 2023-11, Vol.64 (6), p.561-571

2023

Volltextzugriff (PDF)

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation

Oncoimmunology, 2021-01, Vol.10 (1), p.2006529-2006529

2021

Volltextzugriff (PDF)

Bladder tumor ILC1s undergo Th17‐like differentiation in human bladder cancer

Cancer medicine (Malden, MA), 2021-10, Vol.10 (20), p.7101-7110

2021

Volltextzugriff (PDF)

Risk Factor Analysis in a Contemporary Cystectomy Cohort Using Standardized Reporting Methodology and Adverse Event Criteria

The Journal of urology, 2010-03, Vol.183 (3), p.929-934

2010

Volltextzugriff (PDF)

Novel Therapeutic Approaches for Recurrent Nonmuscle Invasive Bladder Cancer

Urologic clinics of North America, 2015-05, Vol.42 (2), p.159-168

2015

Volltextzugriff (PDF)

Clinical outcomes and patterns of population‐based management of urachal carcinoma of the bladder: An analysis of the National Cancer Database

Cancer medicine (Malden, MA), 2022-11, Vol.11 (22), p.4273-4282

2022

Volltextzugriff (PDF)

KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8970-8980

2023

Volltextzugriff (PDF)

Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis

European urology oncology, 2020-06, Vol.3 (3), p.318-340

2020

Volltextzugriff (PDF)

Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

International journal of radiation oncology, biology, physics, 2017-04, Vol.97 (5), p.1002-1020

2017

Volltextzugriff (PDF)

1 – 25 von 338

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

Zeitschrift / SerieUrologic Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(200)

Publikationsform

Artikel
(337)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Life Sciences & Biomedicine
(161)
Humans
(136)
Urology & Nephrology
(109)
Urology
(108)
Male
(96)
Female
(79)
Aged
(75)
Bladder Cancer
(72)
Middle Aged
(71)
Biological And Medical Sciences
(68)
Medical Sciences
(68)
Nephrology. Urinary Tract Diseases
(64)
Urinary Bladder Neoplasms - Pathology
(57)
Oncology
(54)
Urinary Bladder Neoplasms - Surgery
(47)
Tumors Of The Urinary System
(46)
Urinary Tract. Prostate Gland
(45)
Retrospective Studies
(39)
Treatment Outcome
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(128)
European Urology
(38)
The journal Of Urology/the journal Of Urology
(20)
Bju International
(15)
Urology
(14)
Cancer
(11)
The Journal Of Immunology
(9)
Bladder Cancer
(8)
Journal Of Clinical Oncology
(8)
Cancer Research
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Efficacy of Bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers

Definition, Incidence, Risk Factors, and Prevention of Paralytic Ileus Following Radical Cystectomy: A Systematic Review

Chemoradiation Vs Radical Cystectomy for Muscle-invasive Bladder Cancer: A Propensity Score-weighted Comparative Analysis Using the National Cancer Database

Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer

Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma model

Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients

A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2/N3)

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial

Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial

The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

Impact of rural residence on the presentation, management and survival of patients with non-metastatic muscle-invasive bladder carcinoma

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation

Bladder tumor ILC1s undergo Th17‐like differentiation in human bladder cancer

Risk Factor Analysis in a Contemporary Cystectomy Cohort Using Standardized Reporting Methodology and Adverse Event Criteria

Novel Therapeutic Approaches for Recurrent Nonmuscle Invasive Bladder Cancer

Clinical outcomes and patterns of population‐based management of urachal carcinoma of the bladder: An analysis of the National Cancer Database

KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer

Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non–muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis

Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

Aktive Filter

Suchergebnisse filtern